Evidence map›Paper›PMID 40140054›Full record

ReviewInnere Medizin (Heidelberg, Germany)2025

[Obesity as a chronic disease].

Pia Roser, Jens Aberle

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Innere Medizin (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pia RoserIII. Medizinische Klinik, Sektion Endokrinologie und Diabetologie, Universitäres Adipositas-Centrum des UKE, Universitätsklinikum Hamburg-Eppendorf (UKE), Martinistr. 52, 20246, Hamburg, Deutschland. p.roser@uke.de.
Jens AberleIII. Medizinische Klinik, Sektion Endokrinologie und Diabetologie, Universitäres Adipositas-Centrum des UKE, Universitätsklinikum Hamburg-Eppendorf (UKE), Martinistr. 52, 20246, Hamburg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global prevalence of obesity has more than tripled since 1975 and represents a substantial public health challenge. Obesity is a chronic disease with a high tendency to recurrence and is associated with numerous comorbidities, such as diabetes mellitus, high blood pressure and cardiovascular diseases. Every year around 2.8 million people die from the sequelae. Obesity is defined as the excessive accumulation of fatty tissue. In routine clinical practice obesity is diagnosed by measuring the body mass index (BMI); however, there are numerous professional associations that recommend the additional determination of another biometric parameter (waist to height ratio or waist circumference). This not only reduces inaccuracies in the BMI but also makes it easier to identify patients with a particularly high risk of cardiovascular and metabolic diseases. Regardless of the definitions and diagnostics of obesity, the aim of treatment for those affected is not just to reduce weight but more to improve the quality of life, overall survival and the improvement or prevention of obesity-related diseases.

Indexed as

ObesityBody Mass IndexCardiovascular DiseasesChronic DiseaseHumansQuality of LifeBiometric parametersBody Mass IndexMetabolic syndromeObesity, clinicalOverweight

Identifiers

PMID40140054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.